Cite

HARVARD Citation

    Wysham, C. et al. (2016). Baseline factors associated with glycaemic response to treatment with once‐weekly dulaglutide in patients with type 2 diabetes. Diabetes, obesity & metabolism. 18 (11), pp. 1138-1142. [Online]. 
  
Back to record